A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic LeukemiaGuru Subramanian Guru Murthy,Bijal D. Shah,Adam S Duvall,Jessica T. Leonard,Talha Badar,Cecilia Y. Arana Yi,Tyce Kearl,Arielle Baim,Alexandra M. Harrington,Aniko Szabo,Ehab L. AtallahBlood(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要